Newmed Energy-limited Partnership, IL0004750209

NewMed Energy insists gas deal cancelled: 45.34 percent shapes NewMed Energy stock

Published on 10/20/2026 at 09:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The 20-year agreement calls for 1.30 BCM of annual supply at first. A 45.34 percent Leviathan stake anchors NewMed Energy stock.

Contract dispute sets the frame

NewMed Energy reaffirmed the gas agreement cancellation on October 7, 2026.
The Leviathan stake stands at 45.34 percent for the partnership.
TradingView lists November 12, 2026, as the next earnings date.

Newmed Energy-limited Partnership, IL0004750209, Illustration mit AI erstellt.

NewMed Energy-limited Partnership (ISIN IL0004750209) reaffirmed on October 7, 2026, that it considers the USD 6.70 billion Leviathan gas agreement cancelled. Globes reported that Dalia Energy continues to argue that the 20-year deal remains in force.

The dispute matters because NewMed holds 45.34 percent of the Leviathan field. The agreement covers initial combined deliveries of 1.30 billion cubic meters of gas per year, with the volume scheduled to rise to 1.70 billion cubic meters from a later phase, according to The Jerusalem Post.

Three dates define the dispute

On May 19, 2026, NewMed and Ratio signed the USD 6.70 billion gas supply agreement, as reported by The Jerusalem Post. On September 24, 2026, the sellers notified Dalia that they were terminating the USD 6.70 billion agreement, according to MEES. On October 7, 2026, NewMed again maintained that the USD 6.70 billion deal had been cancelled, while Dalia disputed that position, Globes reported.

What does the stake mean for cash flow?

NewMed's 45.34 percent interest gives it the largest seller position in the project, ahead of Ratio's 15.00 percent share, according to MEES. For NewMed, the commercial question is whether the planned 1.30 billion cubic meters of initial annual sales can proceed under the existing terms or must be renegotiated. The disagreement therefore affects the timing and structure of potential gas-related cash flows rather than only the legal wording of the notice.

Next reporting date is November 12

TradingView lists November 12, 2026, as NewMed Energy's next earnings date. The company's investor-relations page identifies the second-quarter 2026 report dated August 13, 2026, and shows the October 7, 2026, termination notice among its immediate reports.

Stock price and investor perspective

NewMed Energy last traded at ILA 1,662.00 on the Tel Aviv Stock Exchange on October 20, 2026, at 10:11 a.m. IDT. The next earnings date gives investors a scheduled point for assessing production, sales and the effect of the disputed contract.